InvestorsHub Logo
Followers 1
Posts 59
Boards Moderated 0
Alias Born 01/17/2017

Re: biocqr post# 793

Sunday, 01/19/2020 10:16:54 PM

Sunday, January 19, 2020 10:16:54 PM

Post# of 977
biocqr - thx for the info, however....

the NR states that - "Under the terms of the agreement, Trillium has granted NeuCyte exclusive, worldwide rights to develop and commercialize the compound." Therefore, it appears that it was not TRIL that in-licensed the product; but rather, the other way around.

Thank goodness, since I don't want to see TRIL spread themselves to thin.